Scientists at the University of Pittsburgh, Department of Transplant Pathology, are using modern digital imaging systems to enhance their research into the chronic rejection in solid organ transplantation and immunobiological mechanisms of tolerance.
ZEISS Axio Scan.Z1, an automated microscope, is a pivotal innovative tool developed by Carl Zeiss Microscopy. This tool allows researchers to convert cytologic specimens and fixed tissue sections using bright-field and fluorescence illumination into digital image files that can be analyzed on a computer screen instead of being tethered to the microscope. (It is the technical sentence)
This form of study gives researchers “next generation pathology” capabilities, including functionality to compare images side by side, comparison, software algorithms for counting, quantification of specific tissue area,analysis etc to increase the amount and type of data that can be collected from a tissue biopsy.
“ZEISS does not stop at building the tool; they work with investigators to ensure you realize the range of capabilities the tool provides in solving biological problems”.
“What sets ZEISS apart is that they understand some of the most challenging aspects of the image acquisition process and develop their technology to solve these problems.” Andrew Lesniak, Senior Architect for the department’s Pathology Informatics Group
Lesniak and his team members believe that the ZEISS Axio Scan.Z1 provides the best imaging and optical hardware, along with analysis software and innovative visualization, to maximize the data that can be obtained from a tissue image.
Hence, Digital pathology promises a bright future. We can expect many more breakthroughs in the field of Digital pathology.
